Delivery Order SPE2DE24D0013-SPE2D626F79L3

Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,800 on January 6, 2026, under a Defense Logistics Agency Medical Supply Chain contract. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic systems and reagents. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in federal procurement. As a manufacturer specializing in advanced molecular diagnostic platforms, including the GeneXpert diagnostic system, Cepheid provides rapid testing capabilities for infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other clinical conditions essential to federal healthcare operations.

This delivery order is part of Cepheid's extensive federal contracting portfolio, which includes significant indefinite delivery contracts with the Department of Veterans Affairs. Most notably, Cepheid holds a single-award indefinite delivery contract with Veterans Integrated Service Network (VISN) 6 valued at $32.8 million through September 30, 2030, and another with VISN 17 valued at $6.7 million through December 28, 2029. These vehicles establish the framework through which Cepheid supplies diagnostic reagents, test kits, and maintenance services across the VA's distributed network of medical centers. The company's federal customer base extends to the Indian Health Service, Defense Health Agency, and U.S. Coast Guard, demonstrating sustained reliance on Cepheid's diagnostic solutions across multiple federal healthcare agencies.